Valuation (22%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -11.38 | -23.05 |
PEG Ratio (TTM) | 1.43 | 15.47 |
P/S Ratio (TTM) | 4,975.19 | 49.46 |
P/B Ratio (TTM) | 2.00 | 18.87 |
P/FCF Ratio (TTM) | -10.49 | -3.27 |
Price to 5YR AVG Earnings Ratio | N/A | -3.55 |
Price to 5YR AVG FCF Ratio | N/A | -9.37 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -16.89% | -5.14% |
ROE (TTM) | -16.39% | 16.69% |
Net Profit Margin (TTM) | -43,707.50% | -1,583.93% |
ROIC 5YR AVG | N/A | 15.15% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -18.71% | -911.91% | N/A |
Revenue | -25.00% | N/A | N/A |
Net Income | -19.01% | -662.19% | N/A |
Cash Flow | -7.11% | -551.18% | N/A |
Health (61%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 19.60 | 6.13 |
Quick Ratio (TTM) | 19.60 | 5.85 |
D/E Ratio (TTM) | 0.00 | -15.81 |
Interest Coverage (TTM) | -114.81 | -1.57 |
Piotroski F-Score | 1 | 5 |
Altman Z-Score | 28.53 | 14.12 |
LTL to 5YR AVG FCF | N/A | 0.17 |
Shares Outstanding Growth 5YR AVG | N/A | 123.44% |